AJP - Renal Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 295: F335-F342, 2008. First published April 16, 2008; doi:10.1152/ajprenal.00077.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/F335    most recent
00077.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, V. W. S.
Right arrow Articles by Harris, D. C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, V. W. S.
Right arrow Articles by Harris, D. C. H.

INVITED REVIEW

Regulatory immune cells in kidney disease

V. W. S. Lee,1 Y. M. Wang,2 Y. P. Wang,1 D. Zheng,1 T. Polhill,2 Q. Cao,1 H. Wu,3 I. E. Alexander,4 S. I. Alexander,2 and D. C. H. Harris1

1Centre of Transplant and Renal Research, Westmead Millennium Institute at University of Sydney, 2Centre for Kidney Research and 4Gene Therapy Research Unit, The Children's Hospital at Westmead, Westmead; and 3Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Lymphocytes and macrophages act as effector immune cells in the initiation and progression of renal injury. Recent data have shown that subpopulations of these immune cells (regulatory T lymphocytes and alternately-activated or regulatory macrophages) are potent modulators of tissue injury and repair in renal disease. Recent animal studies examining the therapeutic effect of these cells raise the exciting possibility that strategies targeting these cell types may be effective in treating and preventing kidney disease in humans. This review will describe their biological role in experimental kidney disease and therapeutic potential in clinical nephrology.

regulatory T lymphocytes; FoxP3; macrophages; dendritic cells; immunotherapy


Address for reprint requests and other correspondence: V. W. S. Lee, Dept. of Renal Medicine, Westmead Hospital, Westmead NSW 2145, Australia (e-mail: vincent_lee{at}wmi.usyd.edu.au)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.